Gene expression profile in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia

Cancer Detection and Prevention

Volumn 32, Issue 4, 2009, Pages 336-337

  Alonso, Vivian ^a   Neves, Adriana F ^a   Marangoni, Karina ^a   Faria, Paula C B ^a   Freschi, Ana Paula P ^a   Capaneli, Andréia C ^a   Meola, Juliana ^a   Goulart, Luiz R ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Gene expression; Peripheral blood; Prostate cancer; Slot blot array

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA;

ADULT; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DNA FRAGMENTATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LETTER; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SLOT BLOT HYBRIDIZATION; TUMOR CELL;

ADULT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, NEOPLASM; HUMANS; MALE; NITRIC OXIDE SYNTHASE TYPE III; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 60749133013     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2008.10.001     Document Type: Letter

References (4)

1. Marangoni K., Neves A.F., Cardoso A.M., Santos W.K., Faria P.C., and Goulart L.R. The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia. Cancer Detect Prev 30 (2006) 7-13
2. Lee M.L.T., Kuo F.C., Whitmore A.A., and Sklar J. Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridisations. PNAS 97 (2000) 9834-9839
3. Nadon R., and Shoemaker J. Statistical issues with microarrays: processing and analysis. Trends Genet 18 (2002) 265-271
4. Medeiros R., Morais A., Vasconcelos A., Costa S., Pinto D., Oliveira J., et al. Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur J Cancer Prev 11 (2002) 343-350